We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy


Repurposing Existing Drugs for Coronavirus: Scripps Research COVID-19 Updates

Video   Mar 24, 2020 | Taken from Scripps Research, YouTube


Scripps Research teams are looking for anti-viral drugs that could be given to people already exposed to the novel coronavirus causing the COVID-19 pandemic. One priority is to test already approved drugs, or drugs with significant safety data in humans available, which could be made available to treat coronavirus patients on a much quicker timescale than new therapies.

To do this, Calibr—the drug development division of Scripps Research—is leveraging a unique resource, the ReFRAME drug repurposing collection. With support from the Bill & Melinda Gates Foundation, Calibr compiled ReFRAME, the world’s leading collection of known drugs, comprising over 14,000 compounds that have been approved by the FDA for other diseases or have been extensively tested for human safety.

Visit Technology Networkshubpage to stay updated with all the latest news on the current coronavirus outbreak

More Information

Recommended Videos

Teach Me in 10 – Dementia Research in 2021 With Ed Pinches


In this installment of Teach Me in 10, we're joined by Ed Pinches, science communications officer at Alzheimer's Research UK, who talks to us about the landscape of dementia research in 2021 and the path to new breakthroughs.


Teach Me in 10 – Materials for Drug Delivery With Professor Robert Langer


For this installment of Teach Me in 10, we are joined by the renowned Professor Robert Langer – the most cited engineer of all time – who talks to us about materials for drug delivery.


Metabolite ID/Characterization Studies FAQ


In this short, information-packed ADME 101 video, one of the principal scientists in our program oversight department discusses the main frequently asked questions that we receive about metabolite identification and characterization studies.



Like what you just watched? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free